Exact Sciences Corp. has licensed technology from a Belgian company that it can use to strengthen the non-invasive DNA-based test for colon cancer it is developing.

The Madison company said it obtained from OncoMethylome Sciences S.A. an exclusive license for up to two DNA methylation biomarkers to use in stool-based detection of colon cancer.

Click Here to read the full article

• Platinum
  
• Silver
  
• Bronze